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Summary
Objective: To investigate the kinetics of early cartilage changes in mechanically induced osteoarthritis (OA) and the association of these
changes with damage to the type II collagen network.
Methods: Experimental OA was induced by anterior cruciate ligament transsection in the rat knee joint (ACLT-OA). Animals were sacrificed
after 2, 7, 14, 28 and 70 days. Knee joints were evaluated using routine histology and immunohistochemistry for denatured (unwound) type
II collagen to detect collagen damage. An antibody recognizing the collagenase cleavage site in type II collagen was used to study the role
of collagenase in this process.
Results: The first changes of the articular cartilage after anterior cruciate ligament transection occurred in the superficial zone. These
changes included loss of superficial chondrocytes, swelling of the remaining chondrocytes and superficial fibrillation. The swelling of the
chondrocytes did not result from a change towards the hypertrophic phenotype, since these cells did not stain for type X collagen. A marked
increase in denatured type II collagen staining was present in the fibrillated areas. Staining of the collagenase cleavage site showed the
same distribution as denatured collagen but was clearly less intense. Collagen damage could never be detected before fibrillation occurred
and was not present in non-fibrillated areas.
Conclusions: These results indicate that in this model cartilage degeneration starts at the articular surface and that this degeneration is
associated with a localized expression of type II collagen degradation products. © 2001 OsteoArthritis Research Society International
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In osteoarthritis (OA), articular cartilage is damaged with a
loss of function. Although little is known of the initiating
events in cartilage degradation in OA, a number of studies
suggest that changes of the superficial cartilage layer are
among the earliest events1–3. In both human4,5 and in
canine experimental OA6,7 the tensile stiffness of the
superficial zone decreased by 40–60%, accompanied
by an increase of the water content of the cartilage7,8.
Biomechanical calculations suggest that damage of the308surface zone leads to increased loading of the cartilage
matrix9, resulting in higher stresses on the underlying
cartilage. This may provide a sequence of events in which
the degeneration of the superficial zone develops into
fibrillation of the cartilage and eventually results in erosions
and ulcerations10–11. The loss of tensile strength and the
increased water content suggest a significant change, i.e.
disruption or disorganization, in the network of highly ori-
entated type II collagen fibrils in the superficial cartilage12.
Immunolocalization of type II collagen degradation prod-
ucts confirmed degeneration of the collagenous network of
the superficial zone during late stage human OA2,13. Dis-
ruption of this network as an initiating event in experimental
OA is suggested by Panula and co-workers14. In dogs with
a tibial valgus osteotomy they found a large increase in
collagen-induced optical path difference that occurred
before surface fibrillation was histologically visible. This
suggests a disruption of the superficial collagen network in
the early phases of OA, preceding fibrillation and further
degeneration of the cartilage. In human OA cartilage
several studies show an elevated activity of matrix
metalloproteinases, including an up-regulation of MMP-1
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collagenous network may be due to increased enzymatic
activity of the chondrocytes.
To study the kinetics of degeneration of the articular
cartilage during OA and the changes of the collagen
network, we investigated damage of type II collagen during
the early phases of experimental, mechanically-induced
OA. We performed immunolocalization directed against
denatured (unwound) type II collagen13 to study damage to
type II collagen. An antibody recognizing the collagenase
cleavage site on the three-quarter fragment of type II
collagen20 was used to investigate collagenase cleavage in
the destruction of this molecule. We show in this model that
cartilage degeneration starts at the articular surface and
that this degeneration is associated with a localized
degradation of type II collagen.Material and methods
ANIMALS
Male Wistar rats (220–240 g) were obtained from the
central animal department breeding facility of the University
of Nijmegen. They were kept in pairs in cages with a
sawdust bedding and had free access to a standard diet
and tap water.ANTERIOR CRUCIATE LIGAMENT TRANSECTION
Rats were anesthetized by inhalation of 2% fluothane
(Zeneca, Macclesfield, U.K.) in oxygen/nitrous oxide. After
shaving the knee joint, the skin was disinfected with iodine
and a parapatellar skin incision was made on the medial
side of the joint. An incision on the medial side of the
patellar tendon provided access to the joint space after
which the patella was dislocated laterally with the leg in
extension. The anterior cruciate ligament was transected
using a custom-made retrograde-cutting hook. A positive
anterior drawer test ensured complete transection of the
ligament. After relocation of the patella, the wound was
closed with vicryl 5/0 (polyglactin 910) braided absorbable
suture (Ethicon, Edinburgh, U.K.). The skin was closed with
two staples and Buprenorfinehydrochloride (80 l, s.c.,
Temgesic®, Reckitt & Colman products, Kingston-upon-
Hull, U.K.) was given as an analgesic. Care was taken to
keep the operation area moist with saline and all operation
procedures were performed using a surgical microscope.
This procedure is modified from the protocol described by
Williams et al.21
Sham operations were performed in the contralateral
knee joint and consisted of opening of the joint space,
subluxation of the patella and closing of the wound.
All procedures were approved by the animal welfare
committee.HISTOLOGY
For routine histology, animals were killed by cervical
dislocation after 2, 7 or 21 (N=24) days, or, in a second
experiment, after 2, 4 and 10 weeks (N=24). Whole knee
joints were dissected, fixed in 4% formalin buffered with
0.1 M phosphate buffer (pH 7.4) and decalcified with 5%
formic acid. After embedding in paraffin, 7 m sections
were cut and stained with hematoxylin/eosin or with
safranin O/fast green.For immunohistochemistry, 24 animals were used and
killed after 2, 4 and 10 weeks after ACL-transection. These
knee joints were dissected and decalcified in 10% EDTA
(Titriplex III, Merck, Darmstadt, Germany) and 7.5% poly-
vinylpyrrolidone (PVP, Mr 29,000, Serva, Brunswick,
Amsterdam, The Netherlands) in 0.1 M Tris buffer (pH 7.4)
for 4 weeks at 4°C22. After extensive rinsing with 7.5% PVP
in 0.1 M Tris buffer, tissue blocks were rapidly frozen in
liquid nitrogen and stored at −70°C. Coronal whole knee
joint sections (7 m) were cut at −18°C on a Bright 3050
cryostat and mounted on glass microscope slides pre-
coated with 3-aminopropyltriethoxysilan (Sigma, St Louis,
MO)2. Sections were air dried for 1 h and stored at −70°C
until further use.ANTIBODIES
To visualize type II collagen degradation, we used anti-
bodies Col2-3/4Cshort (20) and Col2-3/4m (13). Col2-3/
4Cshort is a rabbit polyclonal antibody directed against the
COOH terminus of the three-quarter fragment generated
by cleavage of native type II collagen by mammalian
collagenases. Col2-3/4m is a mouse monoclonal IgG1 that
reacts with an epitope exposed in denatured, but not in
native (helical), type II collagen. It recognizes a 13-residue
amino-acid sequence which is located in the CB11 region
of the three-quarter piece produced by collagenase
cleavage of type II collagen.
Type X collagen was detected with a polyclonal rabbit
antibody raised against a human NC1 synthetic peptide.
The human and mouse sequences of this peptide have
only a single amino acid difference. This antibody did not
show cross-reactivity against collagen type I, II, IX and XI.
In earlier studies it was shown that the collagen type X
polyclonal antibody specifically stained collagen type X in
murine joints23.IMMUNOHISTOCHEMISTRY
After thawing, the sections were fixed in freshly prepared
4% formaldehyde (5 min) and washed extensively in 0.1 M
phosphate buffered saline (pH 7.4; PBS) for 15 min. To
enhance the permeability of the extracellular matrix,
glycosaminoglycans were removed by incubating the
sections with 1% hyaluronidase (testicular, type I-s, EC
3.2.1.35, Sigma, St Louis, MO) in PBS, for 30 min at 37°C.
Endogenous peroxidase activity was blocked by incu-
bation of the sections with freshly prepared 1% (vol/vol)
H2O2 in absolute ethanol for 30 min. Non-specific staining
was blocked by incubation of the sections with 10% normal
goat serum (Col2-3/4C, anti-type X collagen) or with 10%
normal horse (Col2-3/4m) serum in PBS with 1% bovine
serum albumin (Sigma, St Louis, MO).
Sections were incubated overnight with the Col2-3/4C
(1/800), the Col2-3/4m antibody (1/800) or the anti-type X
collagen (1/4000) at 4°C in a humidified chamber. Biotin-
labeled goat anti-rabbit and horse anti-mouse antibodies
(DAKO A/S, Glostrup, Denmark, 1/400) were used as
secondary antibodies (1 h, room temperature). A biotin–
streptavidin detection system (Vectra elite kit, Vectra,
Burlingham, CA) was used according to the manufacturer’s
recommendations. The peroxidase was detected using
tablets containing 10 mg 3′,3′diaminobenzidine (Sigma,
St Louis, MO) dissolved in 15 ml PBS with 12 l H2O2(30%) for 5 min. After rinsing, sections were dehydrated
and mounted with DPX (BDH, Poole, U.K.).
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Two days after operation a small loss of body weight was
observed in both ACL transected and sham-operated rats,
but from 1 week after the operation until the end of the
experiment the body weight of rats in both groups steadily
increased. No statistical differences could be observed
between ACL transected and sham-operated animals.HISTOLOGICAL CHANGES AFTER ACL TRANSSECTION
The articular cartilage from the sham-operated knee
joints was histologically normal, except that occasionallysome dead cells were found in the central part of the medial
tibia. In the unstable knee, degenerative changes were
found in the tibial-femoral compartment, but in most
animals patellar cartilage was unaffected even 10 weeks
post-operatively.Fig. 1. Cartilage surface changes after ACL transection in the femoral–tibial compartment of the rat knee joint. (A), (C–G), (I) HE-stained
sections. (B). H, K. Safranin O/fast green stained sections. (A–C). Control cartilage had a smooth cartilage surface with flat superficial
chondrocytes orientated parallel to the cartilage surface [insert in (C)]. No proteoglycan depletion could be observed. In sham-operated
animals (D) and in the 2-day group (E) no changes compared with control cartilage were observed. (F) After 7 days, slight loss of superficial
chondrocytes was observed. The remaining chondrocytes had a swollen appearance [insert in (F)]. After 4 weeks (G), (H) surface fibrillation
was found on almost the entire cartilage surface. A sharp transition between fibrillated and non-fibrillated cartilage was visible. Arrows in (G)
indicated empty lacunae. In fibrillated areas, loss of safranin O staining was observed (H). The surface fibrillation had increased after 10
weeks (I), (K), again showing loss of safranin O staining in the superficial cartilage zone (K). Magnification: (A), (B) 100×; (C–K) 200×,
inserts 400×.SURFACE CHANGES
In ACL-transected knee joints clear changes of the
surface of the articular cartilage were present, ranging from
swelling of the superficial chondrocytes to complete loss of
the superficial chondrocytes and fibrillation of the super-
ficial zone. In control knee joints [Fig. 1(A), (C)], the
articular cartilage had a smooth surface lined with flat
Osteoarthritis and Cartilage Vol. 9, No. 4 311superficial chondrocytes orientated parallel to the surface.
Safranin O staining was present throughout the cartilage
[Fig. 1(B)]. While the sham-operated [Fig. 1(D)] and 2 days
ACL transected knee joints [Fig. 1(E)] closely resembled
the control group, 7 days after ACL transection scattered
chondrocyte loss was observed [Fig. 1(F)]. The remain-
ing chondrocytes had a swollen appearance [insert in
Fig. 1(F)]. Also slight fibrillation of the articular surface
occurred. This process of fibrillation increased in severity
throughout the duration of the experiment [4 weeks:
Fig. 1(G), (H); 10 weeks: Fig. 1(I), (K)]. Especially in the
4-week group a sharp transition between the non-fibrillated
and fibrillated areas was observed. In the fibrillated areas
the flat superficial chondrocytes were not present or were
no longer recognizable as such and empty lacunae were
often observed [Fig. 1(G)]. Furthermore, loss of safranin O
staining was always found in fibrillated cartilage [Fig. 1(H),
(K)]. Cloning of chondrocytes was apparent in these
damaged areas at 10 weeks [Fig. 1(K)].TYPE X COLLAGEN EXPRESSION AFTER ACL-TRANSECTION
To investigate if the swelling of chondrocytes after ACL
transection was caused by a change towards a hyper-
trophic phenotype, immunohistochemistry for type X colla-
gen was performed. In control, non-operated cartilage, type
X collagen staining was restricted to the hypertrophic zone
of the epiphyseal growth plates [Fig. 2(A), (B)] and to the
calcified zone of the cartilage [Fig. 2(C), (D)]. Staining was
most intense around the hypertrophic cells, but type X
collagen was also present in the interterritorial matrix. In
OA knee joints [Fig. 2(E), (F)], type X collagen staining wasnot found around the swollen chondrocytes in the super-
ficial cartilage zone or elsewhere in the non-calcified zone
of the cartilage.Fig. 2. Type X collagen expression in rat cartilage after anterior cruciate ligament transection. (A), (C), (D). HE-stained sections. (B), (D), (F).
Type X collagen. Polarized light was used in (D) and (F) to show the contours of the cartilage. In control cartilage, type X collagen was
present, as expected, surrounding hypertrophic chondrocytes in the epiphyseal growth plate (A), (B) and in the calcified zone of the articular
cartilage (C), (D). (E), (F) No changes in type X collagen expression were found 10 weeks after ACL transection. Magnification: 100×.TYPE II COLLAGEN DEGRADATION DURING SURFACE FIBRILLATION
In cartilage from unoperated knee joints, type II collagen
degradation could only be observed in the hypertrophic
zone of the calcified cartilage zone. Both denatured type II
collagen [Fig. 3(A)] and the collagenase-cleavage site in
type II collagen [Fig. 3(B)] were found around hypertrophic
chondrocytes. Furthermore, an intense line of type II colla-
gen cleavage was present at the calcified cartilage-bone
interface [Fig. 3(B)].
In contrast, a marked increase in type II collagen dena-
turation was found in fibrillated areas of ACLT-OA knee
joints [Fig. 3(C)]. A sharp transition in the staining pattern
was found between the fibrillated and non-fibrillated areas.
In non-fibrillated cartilage, an increase in denatured colla-
gen was never found. Interestingly, almost no collagenase
cleavage site [Fig. 3(D)] could be observed in areas
showing collagen denaturation.
In areas that were heavily eroded denatured type II
collagen was abundantly present [Fig. 3(E), (F)], while
moderate collagenase cleavage site immunoreactivity
could be detected [Fig. 3(G)]. In the 10 weeks’ group a
similar staining pattern was found: denatured type II colla-
gen stained intensely in fibrillated areas [Fig. 3(H)], while
comparatively little collagenase cleavage site was present
[Fig. 3(I)].
312 R. Stoop et al.: Type II collagen degradation during rat OAFig. 3. Type II collagen degradation in the superficial zone of rat articular cartilage after ACL transection. (A), (B). In control cartilage, collagen
type II denaturation (A) and the collagenase cleavage site (B) could only be observed around hypertrophic chondrocytes (arrows).
Furthermore, the collagenase-cleavage site was present as an intense band on the cartilage–bone interface [arrowheads in (B)]. In surface
fibrillation, denatured type II collagen was clearly present (C), but relatively little collagenase cleavage site was found (D). (E) In heavily
eroded areas denatured type II collagen was abundantly present, but only moderate cleavage site was found (G). (F) Enlargement of (E).
(H), (I). Cartilage surface, 10 weeks after ACL transection. (H), denatured type II collagen, (I), collagenase cleavage site in type II collagen.
Magnification: (A), (B), (E) 100×; (C), (D), (F–I) 200×.Discussion
The first degenerative changes in rat articular cartilage
after transection of anterior cruciate ligament (ACL) were
found in the matrix and chondrocytes of the superficial zone
of the articular cartilage, as in human1,2,10 and experimen-
tal OA in other animal models7,16,24. These changes con-
sisted of loss of superficial chondrocytes, resulting in empty
lacunae, while the remaining chondrocytes had a more
enlarged appearance, resembling chondrocytes from
deeper zones. These results are in accordance with obser-
vations in ACL models in beagles24 and American fox
hounds25. In these dog models, loss of superficial chondro-
cytes and enlargement of the remaining chondrocytes of
the superficial zone were the first changes found. However,
in these animal models this only occurred 1–2 months after
operation, compared to 14 days in the rat model.
Enlargement of superficial chondrocytes may have
several underlying mechanistic causes. First, it may becaused by the decreasing integrity and support of the
pericellular matrix. Second, enlargement of chondrocytes
may indicate swelling prior to hypertrophy or third, may
occur as a sign of increased metabolic activity due to cell
division or increased synthesis of matrix components. In an
attempt to discriminate between these possibilities we
looked at type X collagen expression. It has been described
that type X collagen is expressed in the superficial layer of
normal articular cartilage26,27. If the enlargement of the
remaining chondrocytes represented a change from normal
articular chondrocytes into hypertrophic chondrocytes,
and by this an increase in the normal type X expres-
sion, immune-localization of type X collagen could be
expected. Type X collagen was clearly present in areas
known to contain hypertrophic chondrocytes like the growth
plate28–31 and the calcified zone of articular cartilage32,33.
No changes in the staining pattern for type X collagen were
found in either sham-operated or ACL-transected rats. This
indicates that the enlargement of chondrocytes did not
Osteoarthritis and Cartilage Vol. 9, No. 4 313result from a change into the hypertrophic phenotype.
Although a number of studies showed an increase in type X
collagen expression in OA cartilage, this probably corre-
lates with relatively late events in the OA process. In most
studies increased type X collagen staining could only be
detected in chondrocyte clusters33–35 or in fibrillated
areas35,36. Instead of a change into the hypertrophic
phenotype, the increase in size of the chondrocytes may
reflect an increased ability for synthesis of extracellular
matrix molecules or proteases as a response to the
changed loading pattern. Such increase in synthetic
capacity was also previously found in dog cartilage after
ACL-transection24,25, as indicated by an increase of the
endoplasmic reticulum content of the superficial chondro-
cytes. Finally, it may also indicate that the cells are chang-
ing into chondroblasts with the capacity of cells division or
that the swelling is made possible simply by the lesser
constraint exerted by the damaged pericellular matrix.
The degeneration of the surface zone progressed as a
very localized process, as represented by the differences in
proteoglycan staining between the fibrillated (safranin O
staining absent or reduced) and non-fibrillated areas. That
the changes at the articular cartilage surface also involved
damage to the collagenous network was demonstrated with
immunostaining for type II collagen degradation products.
Increased staining for denatured type II collagen was found
only in fibrillated areas, never in the underlying cartilage.
This indicates that the degeneration of the collagenous
network is a very focal process, which starts at the articular
surface. In recent studies of our laboratory, in which we
studied collagen degradation in two mice stains that
showed spontaneous OA, we used the same antibodies as
in this study37. The pathology observed in these mice
strains is comparable to other spontaneous OA models in
small laboratory animals, such as the guinea-pig, but is
different from the ACLT-OA in the rat. Localized defects
were found, but the surface fibrillation as found in rats was
not present. If we compare the neoepitopes, we found that
also in these mice strains the collagenase cleavage site
also showed very little increase in the degenerated sites.
The COL-2-3/4m antibody was localized to a very small rim
at the outer edge of the degenerated area.
An explanation for the fibrillation in the early OA in the rat
might be an especially thick tangential collagen layer in
rats. If we compared the thickness of the tangential colla-
gen layer in rats and dogs in picrosirius red stained
sections, we found that the layer in the rat is relatively thick
compared to that in the dog. This indicates that the fibril-
lation we observed might be a phenomenon that becomes
particularly clear in early OA in the rat. In human OA
damage to type II collagen also was found to start at the
articular surface where proteoglycan is lost2.
The importance of collagenases in the induction of the
type II collagen denaturation in the superficial cartilage
zone is not completely clear. In comparison with denatured
collagen, the collagenase cleavage site was always less
intense and in a number of sections only staining for
denatured collagen was found. This might reflect direct
mechanical damage to the collagenous network due to the
changed loading pattern, which will expose the denatured
collagen epitope but not the collagenase cleavage site.
On the other hand, a number of studies have indicated
the presence of collagenases (most prominently MMP-1) in
the articular surface zone of experimental and human OA
cartilage, both on the mRNA18,19 and on the protein
level17,38. This implies a role for the cleavage of type II
collagen by collagenases during the OA process irrespec-tive of whether this process is spontaneous or induced
mechanically, as in our study. The low immunoreactivity
might therefore be explained by a difference in processing
after the initial cleavage of type II collagen. The denatured
type II collagen epitope lies relatively far removed from the
cleavage site and is probably more resistant to further
degradation, for example by gelatinases, than the colla-
genase cleavage site where the removal of only one amino
acid leads to loss of immunoreactivity20. Moreover,
Kafienah et al.39 recently showed that cathepsin K is able
to cleave native alpha1(II) chains in the N-terminal region of
the helical domain rather than at the well-defined colla-
genase cleavage site which leads to exposure of the
COL2-3/4m epitope. However, whether this destructive
pathway plays a role in the osteoarthritic process remains
to be established.
In conclusion, this study shows that after transection of
the anterior cruciate ligament in rats the first changes in the
cartilage occurred in the superficial zone. The development
of fibrillation was highly correlated in time and space with
an increase in denatured type II collagen staining. Collagen
damage could never be detected before fibrillation
occurred and was not present in non-fibrillated areas. This
indicates that in this model initial cartilage mechanical
overloading of the surface of the cartilage mainly induces
degeneration. The absence of Col2-3/4Cshort suggests that
collagenases play a minor role in the generation of degen-
eration, which is associated with a localized destruction of
the type II collagen network.Acknowledgments
We would like to thank Diny Versleyen and Elly Vitters
for their histological support and Gerry Grutters, Henny
Eickholt and Geert Poelen for their biotechnical support.Abbreviations
ACL Anterior cruciate ligament
MMP Matrix metallo proteinase
OA Osteoarthritis
PVP Polyvinylpyrrolidone
PBS Phosphate-buffered salineReferences
1. Mitchell N, Lee ER, Shepard N. The clones of osteo-
arthritic cartilage. J Bone Joint Surg Br 1992;74:
33–8.
2. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne
R, Poole AR. Damage to type II collagen in aging and
osteoarthritis starts at the articular surface, originates
around chondrocytes, and extends into the cartilage
with progressive degeneration. J Clin Invest 1995;
96:2859–69.
3. Vignon E, Arlot M, Hartmann D, Moyen B, Ville G.
Hypertrophic repair of articular cartilage in exper-
imental osteoarthrosis. Ann Rheum Diseases 1983;
42:82–8.
4. Akizuki S, Mow VC, Mu¨ller F, Pita JC, Howell DS,
Manicourt DH. Tensile properties of human knee joint
cartilage: I. Influence of ionic conditions, weight bear-
ing, and fibrillation on the tensile modulus. J Orthop
Res 1986;4:379–92.
314 R. Stoop et al.: Type II collagen degradation during rat OA5. Akizuki S, Mow VC, Mu¨ller F, Pita JC, Howell DS.
Tensile properties of human knee joint cartilage. II.
Correlations between weight bearing and tissue
pathology and the kinetics of swelling. J Orthop Res
1987;5:173–86.
6. Setton LA, Mow VC, Mu¨ller FJ, Pita JC, Howell DS.
Mechanical properties of canine articular cartilage
are significantly altered following transection of the
anterior cruciate ligament. J Orthop Res 1994;
12:451–63.
7. Guilak F, Ratcliffe A, Lane N, Rosenwasser MP, Mow
VC. Mechanical and biochemical changes in the
superficial zone of articular cartilage in canine exper-
imental osteoarthritis. J Orthop Res 1994;12:474–84.
8. McDevitt C, Gilbertson E, Muir H. An experimental
model of osteoarthritis; early morphological and bio-
chemical changes. J Bone Joint Surg Br 1977;59:
24–35.
9. Setton LA, Zhu W, Mow VC. The biphasic porovisco-
elastic behavior of articular cartilage: role of the
surface zone in governing the compressive behavior
[see comments]. J Biomech 1993;26:581–92.
10. Byers PD, Maroudase A, Oztop F, Stockwell RA, Venn
MF. Histological and biochemical studies on cartilage
from osteoarthrotic femoral heads with special refer-
ence to surface characteristics. Connect Tissue Res
1977;5:41–9.
11. Venn M, Maroudas A. Chemical composition and swell-
ing of normal and osteoarthrotic femoral head carti-
lage. I. Chemical composition. Ann Rheum Dis 1977;
36:121–9.
12. Kempson GE, Muir H, Pollard C, Tuke M. The tensile
properties of the cartilage of human femoral condyles
related to the content of collagen and glycos-
aminoglycans. Biochim Biophys Acta 1973;297:
456–72.
13. Hollander AP, Heathfield TF, Webber C, Iwata Y,
Bourne R, Rorabeck C, et al. Increased damage to
type II collagen in osteoarthritic articular cartilage
detected by a new immunoassay. J Clin Invest
1994;93:1722–32.
14. Panula HE, Hyttinen MM, Arokoski JPA, Langsjo¨ TK,
Pelttari A, Kiviranta I, et al. Articular cartilage super-
ficial zone collagen birefringence reduced and carti-
lage thickness increased before surface fibrillation in
experimental osteoarthritis. Ann Rheum Dis 1998;57:
237–45.
15. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS,
Woessner JFJ. Evidence for metalloproteinase and
metalloproteinase inhibitor imbalance in human
osteoarthritic cartilage. J Clin Invest 1989;84:678–85.
16. Pelletier JP, Martel-Pelletier J, Altman RD, Ghandur-
Mnaymneh L, Howell DS, Woessner JF Jr. Colla-
genolytic activity and collagen matrix breakdown of
the articular cartilage in the Pond-Nuki dog model of
osteoarthritis. Arthritis Rheum 1983;26:866–74.
17. Fernandes JC, Martel-Pelletier J, Lascau-Coman V,
Moldovan F, Jovanovic D, Raynauld JP, et al.
Collagenase-1 and collagenase-3 synthesis in nor-
mal and early experimental osteoarthritic canine car-
tilage: an immunohistochemical study. J Rheumatol
1998;25:1585–94.
18. Shlopov BV, Lie WR, Mainardi CL, Cole AA,
Chubinskaya S, Hasty KA. Osteoarthritic lesions:
involvement of three different collagenases. Arthritis
Rheum 1997;40:2065–74.19. Freemont AJ, Hampson V, Tilman R, Goupille P, Taiwo
Y, Hoyland JA. Gene expression of matrix metallo-
proteinases 1, 3, and 9 by chondrocytes in osteo-
arthritic human knee articular cartilage is zone and
grade specific. Ann Rheum Dis 1997;56(9):542–9.
20. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A,
Bourne R, Rorabeck C, et al. Enhanced cleavage of
type II collagen by collagenases in osteoarthritic
articular cartilage. J Clin Invest 1997;99:1534–45.
21. Williams JM, Felten DL, Peterson RG, O’Connor BL.
Effects of surgically induced instability on rat knee
articular cartilage. J Anat 1982;134:103–9.
22. Tonnaer EL, Kuijpers W, Peters TA, Ramaekers FC.
Effect of EDTA on cytokeratin detection in the inner
ear. J Histochem Cytochem 1990;38:1223–7.
23. van der Kraan PM, Vitters EL, Meijers THM, Poole AR,
Van den Berg WB. Collagen type I antisense and
collagen type IIa messenger RNA is expressed in
adult murine articular cartilage. Osteoarthritis Cart
1998;6:417–26.
24. Orford CR, Gardner DL, O’Connor P. Ultrastructural
changes in dog femoral condylar cartilage following
anterior cruciate ligament section. J Anat 1983;
137(Pt 4):653–63.
25. Rucklidge GJ, Milne G, Robins SP. Collagen type X. A
component of the surface of normal human, pig, and
rat articular cartilage. Biochem Biophys Res Com
1996;224:297–302.
26. Eerola I, Salminen H, Lammi P, Lammi M, von der
Mark K, Vurio E, et al. Type X collagen, a natural
component of mouse articular cartilage. Arthritis
Rheum 1998;41:1287–95.
27. Pidd JG, Gardner DL, Adams ME. Ultrastructural
changes in the femoral condylar cartilage of mature
American foxhounds following transection of the
anterior cruciate ligament. J Rheumatol 1988;15:
663–9.
28. Alini M, Matsui Y, Dodge GR, Poole AR. The extra-
cellular matrix of cartilage in the growth plate before
and during calcification: changes in composition and
degradation of type II collagen. Calcif Tissue Int
1992;50:327–35.
29. Schmid TM, Linsenmayer TF. Type X collagen. In:
Mayne R, Burgeson RE, Eds. Structure and function
of collagen types. New York: Academic Press 1987:
223–59.
30. Reichenberger E, Aigner T, von der Mark K, Sto¨ss H,
Bertling W. In situ hybridization on the expression of
type X collagen in fetal human cartilage. Dev Biol
1991;148:562–72.
31. Remington MC, Bashey RI, Brighton CT, Jimenez SA.
Biosynthesis of a disulfide bonded short chain colla-
gen by calf growth plate cartilage. Biochem J 1983;
224:227–33.
32. Gannon JM, Walker G, Fischer M, Carpenter R,
Thompson RC Jr, Oegema TRJ. Localization of type
X collagen in canine growth plate and adult canine
articular cartilage. J Orthop Res 1991;9:485–94.
33. Walker GD, Fischer M, Gannon J, Thompson RC Jr,
Oegema TRJ. Expression of type-X collagen in
osteoarthritis. J Orthop Res 1995;13:4–12.
34. von der Mark K, Kirsch T, Nerlich A, Kuss A, Weseloh
G, Glu¨ckert K, et al. Type X collagen synthesis in
human osteoarthritic cartilage. Indication of chondro-
cyte hypertrophy. Arthritis Rheum 1992;35:806–11.
35. Aigner T, Reichenberger E, Bertling W, Kirsch T, Stoss
H, von der Mark K. Type X collagen expression in
Osteoarthritis and Cartilage Vol. 9, No. 4 315osteoarthritic and rheumatoid articular cartilage.
Virchows Arch B Cell Pathol 1993;63:205–11.
36. Eerola I, Salminen H, Lammi P, Lammi M, von der
Mark K, Vuorio E, et al. Type X collagen, a natural
component of mouse articular cartilage: association
with growth, aging, and osteoarthritis. Arthritis
Rheum 1998;41:1287–95.
37. Stoop R, van der Kraan PM, Buma P, Hollander AP,
Billinghurst RC, Poole AR, et al. Type II collagen
degradation in spontaneous osteoarthritis in C57Bl/6
and BALB/c mice. Arthritis Rheum 1999;42:2381–9.38. Moldovan F, Pelletier JP, Hambor J, Cloutier JM,
Martel-Pelletier J. Collagenase-3 (matrix metallopro-
tease 13) is preferentially localized in the deep layer
of human arthritic cartilage in situ: in vitro mimicking
effect by transforming growth factor beta. Arthritis
Rheum 1997;40:1653–61.
39. Kafienah W, Bro¨mme D, Buttle DJ, Croucher LJ,
Hollander AP. Human cathepsin-k cleaves native
type I and II collagens at the n-terminal end
of the triple helix. Biochem J 1998;331(Pt 3):
727–32.
